News Image

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis

Provided By GlobeNewswire

Last update: Sep 12, 2025

SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolisation (GAE) to treat patients with knee osteoarthritis (OA).

Read more at globenewswire.com

MERIT MEDICAL SYSTEMS INC

NASDAQ:MMSI (10/10/2025, 8:44:48 PM)

After market: 78.99 0 (0%)

78.99

-3.49 (-4.23%)



Find more stocks in the Stock Screener

Follow ChartMill for more